Literature DB >> 10821602

Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women.

L M Niccolai1, J J Kopicko, A Kassie, H Petros, R A Clark, P Kissinger.   

Abstract

BACKGROUND AND OBJECTIVES: The presence of sexually transmitted infections (STIs) may facilitate transmission of HIV to uninfected partners. GOAL: To describe the incidence of reinfection with Trichomonas vaginalis in HIV-infected women and to assess predictors of reinfection. STUDY
DESIGN: A retrospective cohort study using data abstracted from medical records of HIV-infected women with at least one diagnosis of trichomoniasis.
RESULTS: Approximately one third (36%) of the study population was reinfected with T vaginalis during the follow-up period, with an incidence of 16.4 reinfections per 100 person years. Significant predictors of reinfection included history of another STI (hazard ratio, 1.52; 95% CI, 1.08-2.14) and becoming pregnant during the follow-up period (hazard ratio, 0.59; 95% CI, 0.39-0.87).
CONCLUSIONS: There is a high rate of reinfection with T vaginalis in HIV-infected women. Further research that includes information on sexual partners should be conducted to better describe the reinfection patterns of trichomoniasis.

Entities:  

Mesh:

Year:  2000        PMID: 10821602     DOI: 10.1097/00007435-200005000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  22 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

3.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

Review 4.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Epidemiology and treatment of trichomoniasis.

Authors:  Patricia Kissinger
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

Review 6.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

7.  A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.

Authors:  Jennifer E Balkus; Barbra A Richardson; Vernon Mochache; Vrasha Chohan; Jeannie D Chan; Linnet Masese; Juma Shafi; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

8.  Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women?

Authors:  Patricia Kissinger; Alys Adamski; Rebecca A Clark; Leandro Mena; Judy Levison; David H Martin
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

9.  Trichomoniasis: clinical manifestations, diagnosis and management.

Authors:  H Swygard; A C Seña; M M Hobbs; M S Cohen
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

Review 10.  Trichomoniasis and HIV interactions: a review.

Authors:  Patricia Kissinger; Alys Adamski
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.